{"name":"Chengdu Qingshan Likang Pharmaceutical Co., Ltd","slug":"chengdu-qingshan-likang-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"glucose peritoneal dialysis solution","genericName":"glucose peritoneal dialysis solution","slug":"glucose-peritoneal-dialysis-solution","indication":"End-stage renal disease requiring peritoneal dialysis","status":"marketed"}]}],"pipeline":[{"name":"glucose peritoneal dialysis solution","genericName":"glucose peritoneal dialysis solution","slug":"glucose-peritoneal-dialysis-solution","phase":"marketed","mechanism":"Glucose peritoneal dialysis solution provides osmotic ultrafiltration during peritoneal dialysis by creating an osmotic gradient across the peritoneal membrane.","indications":["End-stage renal disease requiring peritoneal dialysis","Fluid removal and uremic toxin clearance in peritoneal dialysis patients"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2019-02-22","type":"pipeline","source":"openPR.com","summary":"Peritoneal Dialysis Solution Market to 2025 (+5% CAGR Expected) - openPR.com","headline":"Peritoneal Dialysis Solution Market to 2025 (+5% CAGR Expected)","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}